Overview

Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder

Status:
Completed
Trial end date:
2002-08-01
Target enrollment:
Participant gender:
Summary
This is a research study comparing the safety and efficacy of two active study medications for the treatment of bipolar I disorder.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Olanzapine
Risperidone